Relative factors of catheter-related thrombosis in 172 breast cancer patients with implantable intravenous port

Shi Guo; Luo Feng; Zhang Ling

doi:10.13406/j.cnki.cyxb.000956

您当前的位置：

首页 >

文章列表页 >

Relative factors of catheter-related thrombosis in 172 breast cancer patients with implantable intravenous port

更新时间：2024-01-17

- Relative factors of catheter-related thrombosis in 172 breast cancer patients with implantable intravenous port
- Journal of Chongqing Medical University Vol. 41, Issue 5, Pages: 530-532(2016)
- 作者机构：
  
  重庆医科大学附一院内分泌乳腺外科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.000956
  CLC： R473.73
- Published：2016，
扫描看全文
[1]石果,罗凤,张玲.172例乳腺癌输液港静脉血栓相关因素分析[J].重庆医科大学学报,2016,41(05):530-532.

Shi Guo, Luo Feng, Zhang Ling. Relative factors of catheter-related thrombosis in 172 breast cancer patients with implantable intravenous port. [J]. Journal of Chongqing Medical University 41(5):530-532(2016)
[1]石果,罗凤,张玲.172例乳腺癌输液港静脉血栓相关因素分析[J].重庆医科大学学报,2016,41(05):530-532. DOI： 10.13406/j.cnki.cyxb.000956.

Shi Guo, Luo Feng, Zhang Ling. Relative factors of catheter-related thrombosis in 172 breast cancer patients with implantable intravenous port. [J]. Journal of Chongqing Medical University 41(5):530-532(2016) DOI： 10.13406/j.cnki.cyxb.000956.

摘要

目的:通过对172例乳腺癌患者输液港临床资料回顾性总结

分析静脉血栓形成原因。方法:收集2013年11月至2014年12月就诊于重庆医科大学附属第一医院内分泌外科172例乳腺癌患者性别、年龄、港安置和肿瘤位置、化疗方案及局部静脉彩超等临床资料

分析静脉血栓形成的影响因素。结果:172例乳腺癌患者采用左颈内静脉或右颈内静脉置港化疗的人数分别为48和124例。共有42例（42/172

24.4%）患者发生静脉血栓

其中左颈内静脉16例（16/48

33.3%）

右侧26例（26/124

21.0%）

（P>0.05）;化疗TEC/EC-T方案32例（32/42

76.2%）

TAC方案5例（5/42

11.9%）

CEF/FEC方案2例（2/42

4.8%）

EC方案3例（3/42

7.1%）

（P<0.001）;化疗第1疗程2例（2/42

4.8%）

化疗第2疗程5例（5/42

11.9%）

第3、4、5、6疗程分别有9例（9/42

21.4%）

12例（12/42

28.6%）

8例（8/42

19.0%）和6例（6/42

3%）。结论:静脉血栓形成是输液港临床应用中较常见的并发症

颈内静脉左侧为好发部位

但无统计学差异（P>0.05）。化疗周期与静脉血栓形成的关系不大（P>0.05）。不同的化疗药物是引起静脉血栓形成的主要因素

TEC/EC-T方案最容易引起静脉血栓（P<0.001）。

Abstract

Objective:To explore factors affecting port venous thrombosis in breast cancer patients. Methods:Data of 172 breast cancer patients admitted to the First Affiliated Hospital of Chongqing Medical University from November2013 to December 2014 were collected and analyzed in regard of gender

age

implantable sites

tumor location

chemotherapy regimens and colorful ultrasound results.Results:Catheter-related thrombosis occurred in 42 out of 172 patients(42/172

24.4%)with implantable intravenous port including16 cases(16/48

33.3%) of left side internal jugular vein

26 cases(26/124

21.0%) on the right side(P >0.05)

32 cases(32/42

76.2%)with TEC/ECT scheme

5 cases(5/42

11.9%)with the TAC scheme

2 cases(2/42

4.8%)with CEF/FEC scheme

3 cases(3/42

7.1%)with EC scheme(P<0.001)

5 cases(5/42

11.9%)in 2nd chemotherapy cycle

8 cases(8/42

19.0%)and 6 cases(6/42

14.3%)in 5th and 6th chemotherapy cycles

respectively(P >0.05). Conclusion:Catheter-related thrombosis is a common complication in breast cancer patients with implantable intravenous port and the left side is the predilection site. There is no correlation between venous thrombosis and chemotherapy cycles. Chemotherapy drugs may be responsible for formation of thrombosis and TEC/ECT regime is the most likely cause.

关键词

输液港乳腺癌血栓影响因素

Keywords

portbreast cancerthrombosisAffecting factors

references

Views

491

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Pathomics signature based on machine learning can predict the response to neoadjuvant chemotherapy in breast cancer patients

Effects of circular RNA hsa_circ_0002185 on cell viability and invasion of breast cancer cells and its mechanism of action

Prediction and identification of H-2Kd restricted CTL epitope derived from breast cancer associated antigen ROR1

Comparison of lung dosimetry between supine and sternal horizon positions during X-ray irradiated radical mastectomy radiation therapy

Membrane estrogen receptor expression in breast cancer and its effect on epidermal growth factor

Related Author

Zhang Jieqiu

Wu Qi

Wang Jianmei

Yao Xiaopeng

Shaojie Qin

Mingliang Ning

Qingyuan Liu

Zhenning Tang

Related Institution

Department of Epidemiology and Health Statistics， School of Public Health，Southwest Medical University

Department of Pathology，The Affiliated Hospital of Southwest Medical University

Department of Medical Engineering Technology，School of Medical Information and Engineering，Southwest Medical University

Oncological Surgery Third Department, General Hospital of Ningxia Medical University

Department of Pathophysiology,College of Basic Medicine,Chongqing Medical University,Laboratory of Stem Cell and Tissue Engineering

⁰